KILITCH DRUGS (INDIA)
Back to Cashflow Statement
|
KILITCH DRUGS (INDIA) Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹24 Cr | ₹18 Cr | ₹-1.53 Cr | ₹2.59 Cr | ₹5.78 Cr |
What is the latest Cash Flow from Operating Activities ratio of KILITCH DRUGS (INDIA) ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹24 Cr |
| Mar2025 | ₹18 Cr |
| Mar2024 | ₹-1.53 Cr |
| Mar2023 | ₹2.59 Cr |
| Mar2022 | ₹5.78 Cr |
How is Cash Flow from Operating Activities of KILITCH DRUGS (INDIA) Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹24 Cr | 36.58 | |
| Mar2025 | ₹18 Cr | Positive | |
| Mar2024 | ₹-1.53 Cr | Negative | |
| Mar2023 | ₹2.59 Cr | -55.28 | |
| Mar2022 | ₹5.78 Cr | - | |
Compare Cash Flow from Operating Activities of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹678.3 Cr | 3.7% | 21.5% | 4.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,398.0 Cr | -0.4% | -3.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,664.0 Cr | 0.4% | 9.9% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,738.0 Cr | -3.4% | -4.2% | 37.1% | Stock Analytics | |
| CIPLA | ₹110,794.0 Cr | 0.5% | -3.2% | -12.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,749.4 Cr | 0.9% | 0% | -11% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | 3.7% |
21.5% |
4.6% |
| SENSEX | -0.8% |
-3.8% |
-8.9% |
You may also like the below Video Courses